Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

47.73 -0.30 (-0.62%)
Streaming Delayed Price Updated: 10:19 AM EST, Dec 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
April 05, 2005
Form 8-K/A
Source: SEC/Edgar
April 04, 2005
Form S-2
Source: SEC/Edgar
April 04, 2005
Form 8-K
Source: SEC/Edgar
April 03, 2005
Form 424B3
Source: SEC/Edgar
March 31, 2005
Form 8-K
Source: SEC/Edgar
March 31, 2005
Form 8-K
Source: SEC/Edgar
March 29, 2005
Form 8-K
Source: SEC/Edgar
March 29, 2005
Form 10KSB/A
Source: SEC/Edgar
March 28, 2005
Form 424A
Source: SEC/Edgar
March 28, 2005
Form 8-K
Source: SEC/Edgar
March 27, 2005
Form SC 13G/A
Source: SEC/Edgar
March 21, 2005
Form 8-K/A
Source: SEC/Edgar
March 16, 2005
Form 10KSB
Source: SEC/Edgar
March 10, 2005
Form DEF 14C
Source: SEC/Edgar
March 10, 2005
Form 8-K
Source: SEC/Edgar
March 08, 2005
Form PRER14C
Source: SEC/Edgar
March 08, 2005
Form 8-K
Source: SEC/Edgar
March 08, 2005
Form 10QSB
Source: SEC/Edgar
February 21, 2005
Form 8-K
Source: SEC/Edgar
February 21, 2005
Form SC 13G/A
Source: SEC/Edgar
February 17, 2005
Form SC 13G/A
Source: SEC/Edgar
February 13, 2005
Form NT 10-Q
Source: SEC/Edgar
February 13, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Form SC 13G
Source: SEC/Edgar
February 10, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.